Study of Drug Eluting Peripheral Vascular Stent System in Superficial Femoral Artery Stenosis and /or Occlusion
The Safety and Efficacy of Drug Eluting Peripheral Vascular Stent System for the Treatment of Superficial Femoral Artery Stenosis and /or Occlusion: a Multi-center Stratified Randomized Single- Blind Controlled Trial
Sponsor: Guangzhou Osmunda Medical Device Technology, Inc., Ltd.
Listed as NCT03121430, this NA trial focuses on Peripheral Arterial Disease and Superficial Femoral Artery Occlusion and remains ongoing. Sponsored by Guangzhou Osmunda Medical Device Technology, Inc., Ltd., it has been updated 7 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Oct 2021 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
-
Mar 2019 — Jan 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
▶ Show 2 earlier versions
-
Jun 2018 — Mar 2019 [monthly]
Not Yet Recruiting NA
-
May 2017 — Jun 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Guangzhou Osmunda Medical Device Technology, Inc., Ltd.
- Zhejiang Zylox Medical Device Co., Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .